Untitled Document
Taking a Closer Look at the Stories Ignored by the Corporate Media
Donate | Fair Use Notice | Who We Are | Contact

NEWS
All News
9-11
Corporatism
Disaster in New Orleans
Economics
Environment
Globalization
Government / The Elite
Human Rights
International Affairs
Iraq War
London Bombing
Media
Police State / Military
Science / Health
Voting Integrity
War on Terrorism
Miscellaneous

COMMENTARY
All Commentaries
9-11
CIA
Corporatism
Economics
Government / The Elite
Imperialism
Iraq War
Media
Police State / Military
Science / Health
Voting Integrity
War on Terrorism

SEARCH/ARCHIVES
Advanced Search
View the Archives

E-mail this Link   Printer Friendly

SCIENCE / HEALTH -
-

US Tots Used As AntiPsychotic Drug Guinea Pigs?

Posted in the database on Monday, May 22nd, 2006 @ 13:01:26 MST (1894 views)
by Joseph Rhee    Rense.com  

Untitled Document

ABC News has learned that a Massachusetts hospital is currently recruiting pre-schoolers to test the safety and effectiveness of a powerful antipsychotic drug called Quetiapine.

The study, conducted by the Department of Pediatric Psychopharmacology at Massachusetts General Hospital, is testing subjects from four to six years of age with Bipolar Disorder. An earlier Massachusetts General study of the antipsychotic drugs Risperidone and Olanzapine recruited children as young as three years old.

These antipsychotic drugs are only approved for use by adults and are so toxic they carry a "black box warning." The drugs have been found to cause diabetes; a life-threatening nervous system problem called Neuroleptic Malignant Syndrome; low blood pressure; and have also led to higher death rates in the elderly. Despite these serious potential side-effects, a patient recruitment video obtained by ABC News contains no mention of any of these risks.

Vera Hassner Sharav of the Alliance for Human Research Protection said, "Antipsychotics were never approved for use in children whose developing brains and central nervous system may be irreversibly harmed. We believe that physicians who subject children to the toxic effects of these drugs...are practicing outside medically accepted standards."

A previous clinical trial of Olanzapine was conducted by UCLA in 1998 on five children, aged 6 to 11. The authors of the study said treatment was discontinued within the first six weeks "because of adverse effects or lack of clinically significant therapeutic response."

Sharav also said it's questionable whether or not three or four year-olds can be accurately diagnosed for Bipolar Disorder. According to a 1999 Surgeon General report, "The signs and symptoms of mental disorders are often also the characteristics of normal development." The National Institute for Mental Health has concluded that "diagnostic uncertainty...surrounds most manifestations of psychopathology at such an early age."

Neither the hospital nor the lead investigator for the trials, Dr. Joseph Biederman, responded to our requests for a comment on the trials.

Go here for information on the Massachusetts General clinical trial

http://www.clinicaltrials.gov/ct/show/NCT00181883?order=1

Joseph Rhee Reports
ABC News

______________________________

Merck Targets Children for Sex Disease Vaccine
by
CONSPIRACY PLANET

In the hallowed New Jersey tradition of "Pass a law; Make a business" drug company giant Merck & Co. is pressuring Congress to mandate a vaccine that will target 32 million children in the U.S. for a sexually transmitted virus that allegedly causes cervical cancer, reports Bloomberg. (http://quote.bloomberg.com/apps/news?
pid=10000006&sid=a4rAeg.xClu0&refer=home
)

Mandated vaccines like Merck's Gardasil which is billed as a preventative measure against HPV (Human Papilloma Virus) will ensure a steady revenue stream for the giant pharmaceutical company, which evidently requires government guarantees and mandates to retain their egregious profits.

According to Bloomberg, Merck claims Gardasil is "the most important product Merck is developing and analysts say it may generate $3 billion in annual sales...

"Merck will present evidence to a government committee that the vaccine works best in youngsters before they become sexually active. The drugmaker's pitch for universal immunization as early as age nine may be a tough sell with parents worried about adding another routine childhood vaccine.

Bloomberg also reports that the FDA (Food and Drug Administration) will decide to approve Gardasil by June 8 under a priority-review process.

The so-called revolving door between government regulators and drug companies has been well-documented, and, sure enough, Bloomberg also reports that "an FDA staff report yesterday said Gardasil appears safe and effective."

"Safe and effective"? At least until the Vioxx-style class action lawsuits begin.

Sounds like the FDA staffer that wrote that "drug promotion" can move right into Merck after "retiring" from government.

Since the FDA is just the marketing and publicity arm of Big Pharma, it should be a very smooth transition into the "private sector."



Go to Original Article >>>

The views expressed herein are the writers' own and do not necessarily reflect those of Looking Glass News. Click the disclaimer link below for more information.
Email: editor@lookingglassnews.org.

E-mail this Link   Printer Friendly




Untitled Document
Disclaimer
Donate | Fair Use Notice | Who We Are | Contact
Copyright 2005 Looking Glass News.